Whole-genome sequencing of patients with rare diseases in a national health system
Most patients with rare diseases do not receive a molecular diagnosis and the aetiological variants and causative genes for more than half such disorders remain to be discovered. Here we used whole-genome sequencing (WGS) in a national health system to streamline diagnosis and to discover unknown ae...
Prif Awduron: | Turro, E, Astle, WJ, Megy, K, Bennett, DL, Ormondroyd, E, Roberts, I, Roy, NBA, Themistocleous, A, Watkins, H |
---|---|
Awduron Eraill: | NIHR BioResource for the 100,000 Genomes Project |
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Springer Nature
2020
|
Eitemau Tebyg
-
Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
gan: Mackley, M, et al.
Cyhoeddwyd: (2018) -
Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
gan: Ormondroyd, E, et al.
Cyhoeddwyd: (2016) -
Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
gan: C Camps, et al.
Cyhoeddwyd: (2018) -
Whole genome sequencing for the investigation of rare anaemias: challenges and real-world outcomes
gan: Brierley, C, et al.
Cyhoeddwyd: (2019) -
Editorial: Whole Genome Sequencing for rare diseases
gan: Chiara Di Resta, et al.
Cyhoeddwyd: (2023-09-01)